Q. PROVENGE is a vaccine treatment for which of the following cancer
a. hepatoma
b. multiple myeloma
c. prostate cancer
d. hodgkin lymphoma
ANSWER:
answer: C
Provenge (generic name sipuleucel-T) is an immunotherapy for prostate cancer manufactured by Dendreon. It received U.S. Food and Drug Administration (FDA) approval for use in the treatment of advanced prostate cancer patients on April 29, 2010. It is the first FDA approved drug in its class.
No comments:
Post a Comment
Ask your doubts / point out towards any error / show appreciation / explain anything you wish to.